Skip to content

    Inspire Medical Systems (INSP) stock price & financials

    View INSP earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance33.4% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $203.19M
    $239.72M
    $201.32M
    $217.09M
    $224.50M
    +10.5%
    $269.08M
    +12.2%
    $204.58M
    +1.6%
    $200.58M
    -7.6%
    Stable
    Operating Profit
    $14.32M
    $31.88M
    -$1.49M
    -$3.32M
    $9.64M
    -32.6%
    $46.11M
    +44.6%
    -$1.12M
    +24.7%
    -$514.0K
    +84.5%
    Strengthening
    Net Profit
    $18.50M
    $35.22M
    $2.99M
    -$3.59M
    $9.93M
    -46.3%
    $136.09M
    +286.4%
    -$11.29M
    -477.5%
    $314.0K
    Weakening
    EPS
    $0.62
    $0.10
    $-0.12
    $0.34
    -45.2%
    $-0.39
    -490.0%
    $0.01
    Weakening
    Other Income
    $6.01M
    $4.75M
    $5.64M
    $984.0K
    $3.91M
    -35.0%
    $4.21M
    -11.4%
    Weakening
    Interest
    $0
    $4.0K
    $11.0K
    Depreciation
    Profit before Tax
    $20.33M
    $36.64M
    $4.16M
    -$2.33M
    $13.55M
    -33.3%
    $50.32M
    +37.3%
    $2.40M
    -42.4%
    $3.12M
    Stable
    MarginsOPM
    7.0%
    13.3%
    -0.7%
    -1.5%
    4.3%
    -39.0%
    17.1%
    +28.9%
    -0.6%
    +25.7%
    -0.3%
    +83.0%
    Strengthening
    Tax
    9.0%
    3.9%
    28.1%
    -54.0%
    26.7%
    +196.8%
    -170.4%
    -4527.3%
    571.2%
    +1935.5%
    89.9%
    Weakening
    ReturnsROIC
    -11.7%
    -22.4%
    -1.9%
    2.3%
    -6.3%
    +46.3%
    -86.4%
    -286.4%
    7.2%
    -0.2%
    -108.7%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$97.29M$22.86M$190.52M$214.47M$441.59M$185.54M$150.15M$104.81M$127.76M
    Short-Term Investments
    Total Current Assets$199.28M$170.64M$269.87M$268.54M$530.03M$593.74M$630.81M$583.65M$608.67M
    Net PP&E$802.0K$3.96M$11.12M$16.41M$24.13M$62.65M$95.24M$121.40M$126.93M
    Goodwill
    Intangibles
    Total Assets$200.08M$181.25M$281.19M$295.08M$564.88M$676.81M$808.38M$907.32M$925.99M
    LiabilitiesTotal Current Liabilities$11.15M$16.86M$20.73M$41.31M$61.19M$78.11M$88.50M$96.06M$71.18M
    Short-Term Debt
    Long-Term Debt$24.50M$24.50M$24.50M$24.50M
    Long-Term Leases$0$5.89M$8.80M$7.54M$24.85M$30.04M$30.00M$29.09M
    Total Liabilities$36.08M$41.42M$51.44M$66.04M$68.87M$104.30M$118.69M$126.16M$100.41M
    EquityCommon Stock & APIC$23.0K$24.0K$27.0K$27.0K$29.0K$30.0K$30.0K$29.0K$29.0K
    Retained Earnings-$146.91M-$180.16M-$237.35M-$279.39M-$324.27M-$345.42M-$291.91M-$146.49M-$157.47M
    Total Equity$164.00M$139.84M$229.75M$229.05M$496.01M$572.51M$689.70M$781.16M$825.58M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$18.69M-$32.85M-$53.05M-$20.12M$11.57M$24.65M$130.25M$116.98M$157.07M
    Cash from Investing-$83.39M-$43.56M$86.63M$29.14M-$19.60M-$294.82M-$113.12M$21.45M-$31.26M
    Cash from Financing$190.38M$1.96M$134.06M$14.95M$235.08M$13.95M-$52.39M-$183.45M-$104.96M
    SummaryCapital Expenditure-$250.0K-$2.74M-$2.46M-$4.67M-$9.10M-$23.63M-$39.12M-$38.50M-$39.98M
    Free Cash Flow-$18.94M-$35.59M-$55.50M-$24.79M$2.47M$1.02M$91.12M$78.48M$117.09M
    FCF Margin-37.4%-43.4%-48.1%-10.6%0.6%0.2%11.4%8.6%13.0%

    Ratios